Modulation of conditioned avoidance response and quetiapine-induced metabolic syndrome by rosuvastatin and CDP-choline in rats

Modulation of conditioned avoidance response and quetiapine-induced metabolic syndrome by rosuvastatin and CDP-choline in rats

Sir, Metabolic syndrome diabetes mellitus, lipid abnormalities, and weight gain have increasingly been recognized with the use of the newer, atypical antipsychotic drugs like quetiapine. [4],[5] In this regards study was conducted to find out the effect on glucose, serum triglyceride, and liver glyc...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmacology & pharmacotherapeutics Vol. 4; no. 4; pp. 283 - 285
Main Authors: Shafique, Ahmad, Pillai, K K, Hasan, Abdi Sayed Aliul, Najmi, A K
Format: Journal Article
Language:English
Published: India Medknow Publications and Media Pvt. Ltd 01-10-2013
Sage Publications Ltd
Medknow Publications & Media Pvt Ltd
Subjects:
Bipolar disorder
Blood sugar
Diabetes
Drug therapy
Glucose
Health care
Metabolic diseases
Metabolic syndrome
Observations
Patient outcomes
Psychotropic drugs
Quetiapine
Research Letter
Risk factors
Schizophrenia
Triglycerides
India
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sir, Metabolic syndrome diabetes mellitus, lipid abnormalities, and weight gain have increasingly been recognized with the use of the newer, atypical antipsychotic drugs like quetiapine. [4],[5] In this regards study was conducted to find out the effect on glucose, serum triglyceride, and liver glycogen with combination of quetiapine (QT) with rosuvastatin (RS) and QT with cytidine diphosphate-choline (CDC) in CAR-induced rats.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0976-500X
0976-5018
DOI:10.4103/0976-500X.119715